InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（6 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
6
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Chu Yu-Waye. Director active across 2 companies, notably Fate Therapeutics INC. Aggregated, 12 disclosures have been published. Split: 0 buy · 6 sells. Total volume traded: €445k. Activity tracked since 19 November 2021. The latest transaction was filed on 17 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Chu Yu-Waye
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
21,279 股@ US$6.42398.2% 占其流量Common StockSEC:0001610717-26-000125:0
75,000 股0Common StockSEC:0001610717-26-000042:0
4,025 股@ US$0.599100.0% 占其流量Common StockSEC:0001610717-25-000084:0
56,000 股0Common StockSEC:0001610717-25-000018:0
26,250 股0Common StockSEC:0001610717-24-000031:0
215 股@ US$6.520.2% 占其流量Common StockSEC:0001209191-23-024820:0
7,825 股@ US$5.245.5% 占其流量Common StockSEC:0001209191-23-002974:0
4,062 股@ US$35.3730.8% 占其流量Common StockSEC:0001209191-22-025159:0
33,302 股0Common StockSEC:0000899243-22-003448:0
3,547 股@ US$48.4435.1% 占其流量Common StockSEC:0001209191-22-003166:0
7,500 股@ US$16.3225.1% 占其流量Common StockSEC:0001209191-21-069313:0
60,958 股0Common StockSEC:0001209191-21-066156:0
12 条申报中的 12 条
About Chu Yu-Waye
Chu Yu-Waye is a declarant linked to Fate Therapeutics INC, where the role is Chief Medical Officer, and to CytomX Therapeutics, Inc., where the role is Chief Medical Officer. Across 12 filings in total, the 12 sampled filings span 2021-11-22 to 2026-03-19 and show EUR 445281 in sales and EUR 0 in purchases, with Cession as the modal transaction nature.
